Dr. Ryan M. Rhome
Overview
Ryan Rhome is a Radiation Oncologist in Chicago, Illinois. Dr. Rhome is rated as an Advanced provider by MediFind in the treatment of Triple-Negative Breast Cancer. His top areas of expertise are Fibrolamellar Carcinoma, Breast Cancer, Triple-Negative Breast Cancer, and Anal Cancer.
His clinical research consists of co-authoring 27 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Triple-Negative Breast Cancer.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- EPO
- HMO
- PPO
- MEDICARE MAPD
- OTHER MEDICARE
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
900 W Nelson St, Chicago, IL 60657
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Advocate Radiation Oncology
Harsha Varadhi is a Radiation Oncologist in Palos Heights, Illinois. Dr. Varadhi is rated as an Advanced provider by MediFind in the treatment of Triple-Negative Breast Cancer. His top areas of expertise are Breast Cancer, Pleuropulmonary Blastoma, HER-2 Positive Breast Cancer, and Triple-Negative Breast Cancer.
Radiation Oncology Consultants, Ltd
Arica Hirsch is a Radiation Oncologist in Park Ridge, Illinois. Dr. Hirsch is rated as a Distinguished provider by MediFind in the treatment of Triple-Negative Breast Cancer. Her top areas of expertise are Familial Prostate Cancer, Posterior Fossa Tumor, Pleuropulmonary Blastoma, and Lung Cancer.
Radiation Oncology Consultants, Ltd
Michael Kharouta is a Radiation Oncologist in Chicago, Illinois. Dr. Kharouta is rated as an Advanced provider by MediFind in the treatment of Triple-Negative Breast Cancer. His top areas of expertise are Breast Cancer, HER-2 Positive Breast Cancer, Lung Cancer, and Endometrial Cancer.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Anal CancerDr. Rhome isAdvanced. Learn about Anal Cancer.
- Breast CancerDr. Rhome isAdvanced. Learn about Breast Cancer.
- Familial Pancreatic CancerDr. Rhome isAdvanced. Learn about Familial Pancreatic Cancer.
- Fibrolamellar CarcinomaDr. Rhome isAdvanced. Learn about Fibrolamellar Carcinoma.
- Intraductal PapillomaDr. Rhome isAdvanced. Learn about Intraductal Papilloma.
- Metastatic Brain TumorDr. Rhome isAdvanced. Learn about Metastatic Brain Tumor.
- Experienced
- Acinic Cell Carcinoma of Salivary Glands
- Adrenal CancerDr. Rhome isExperienced. Learn about Adrenal Cancer.
- Adrenocortical CarcinomaDr. Rhome isExperienced. Learn about Adrenocortical Carcinoma.
- Adult Soft Tissue SarcomaDr. Rhome isExperienced. Learn about Adult Soft Tissue Sarcoma.
- ALK-Positive Non-Small Cell Lung Cancer
- Alveolar Soft Part SarcomaDr. Rhome isExperienced. Learn about Alveolar Soft Part Sarcoma.